Category: 4. Health

Gears are everywhere – from clocks and cars to robots and wind turbines. For more than 30 years, researchers have been trying to create even smaller gears in order to construct micro-engines. But progress stalled at 0.1 millimeters, as it was not possible to build the drive trains needed to make…

The findings, published on September 8 in Cancer Discovery, are the first to…

Trump officials intend to link 25 child deaths to COVID-19 vaccines, according to reporting from The Washington Post. These findings will reportedly be discussed during the Sept. 18-19, 2025, meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, with implications for who may be eligible for COVID-19 vaccines in the future.

These death reports are reportedly derived from the Vaccine Adverse Event Reporting System, or VAERS, a…

In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here.

Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation…

The nation’s biggest…

Amid the petty drama of internet arguments, one never fails to entertain me: Do millennials actually look younger than their age? Sunscreen, vaping, hair parting choices and Botox for people who don’t have wrinkles are used as evidence for and against this generational Dorian Graying. I can’t and won’t adjudicate this debate. But I can shift the conversation away from TikTok and inward to the brain.

Brain age isn’t a new concept, especially for people trying to make…

A new drug may help people with high blood pressure that does not respond to existing medications.

The results of a large clinical trial, published August 30 in the New England Journal of Medicine, suggest that baxdrostat could offer an alternative for people with resistant hypertension — high blood pressure that stays elevated despite standard therapy. Baxdrostat is one of a new class of drugs called aldosterone synthase inhibitors.

High blood pressure affects 1.3 billion…